Correction (DOI:10.1016/j.nuclcard.2007.08.002);Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio

Journal of Nuclear Cardiology

Volumn 14, Issue 6, 2007, Pages 843-851

  Nakajima, Kenichi ^a   Matsubara, Kosuke ^b   Ishikawa, Takehiro ^c   Motomura, Nobutoku ^d   Maeda, Ryo ^c   Akhter, Nasima ^a   Okuda, Koichi ^a   Taki, Junichi ^a   Kinuya, Seigo ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c FUJIFILM CORPORATION   (Japan)

^d TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

Author keywords

123I meta iodobenzylguanidine; collimator; iodine dual energy window method; quantification; triple energy window method

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ARTICLE; CLINICAL ARTICLE; COLLIMATOR; CONTROLLED STUDY; DRUG UPTAKE; HEART; HEART DISEASE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER; LUNG; MEDIASTINUM; PHANTOM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION; STATISTICAL SIGNIFICANCE; THEORETICAL STUDY;

EID: 36048981515     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.11.014     Document Type: Erratum

References (26)

1. Hattori N., and Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically?. Eur J Nucl Med 27 (2000) 1-6
2. Yamashina S., and Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imag 34 (2007) 562-573
3. Momose M., Tyndale-Hines L., Bengel F.M., and Schwaiger M. How heterogeneous is the cardiac autonomic innervation?. Basic Res Cardiol 96 (2001) 539-546
4. Tamaki N., Kusakabe K., Kubo A., Kumasaki T., Shimamoto K., and Senda S. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J 69 Suppl IV (2005) 1125-1202
5. Yamashina S., and Yamazaki J. Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence. Eur J Nucl Med Mol Imag 31 (2004) 1353-1355
6. 123I-metaiodobenzylguanidine in chronic heart failure: is there a clinical use?. Nucl Med Commun 27 (2006) 927-931
7. 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 15 (1994) 317-323
8. Somsen G.A., Verberne H.J., Fleury E., and Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol 11 (2004) 126-133
9. Inoue Y., Suzuki A., Shirouzu I., Machida T., Yoshizawa Y., Akita F., et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 10 (2003) 623-632
10. Inoue Y., Shirouzu I., Machida T., Yoshizawa Y., Akita F., Minami M., et al. Collimator choice in cardiac SPECT with I-123-labeled tracers. J Nucl Cardiol 11 (2004) 433-439
11. Verberne H.J., Feenstra C., de Jong W.M., Somsen G.A., van Eck-Smit B.L., and Busemann Sokole E. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imag 32 (2005) 1100-1107
12. Motomura N., Ichihara T., Takayama T., Aoki S., Kubo H., and Takeda K. Practical compensation method of downscattered component due to high energy photon in 123I imaging. [abstract in English]. Kaku Igaku (Jpn J Nucl Med) 36 (1999) 997-1005
13. Kobayashi H., Momose M., Kanaya S., Kondo C., Kusakabe K., and Mitsuhashi N. Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems. Ann Nucl Med 17 (2003) 309-313
14. Nakajima K., Motomura N., Matsubara K., Ishikawa T., Maeda R., Taki J., et al. Quantification of I-123 MIBG uptake by triple-energy window and dual-window methods independent on collimator selection. [abstract]. J Nucl Med 47 (2006) 257P-258P
15. Ichihara T., Ogawa K., Motomura N., Kubo A., and Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med 34 (1993) 2216-2221
16. 123I cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun 27 (2006) 551-558
17. Chen J., Garcia E.V., Galt J.R., Folks R.D., and Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 13 (2006) 251-260
18. Nishimura T. Heart failure and cardiac sympathetic neuronal function. [in Japanese] (2002), Medical View, Tokyo 148-155
19. Richalet J.P., Merlet P., Bourguignon M., Le-Trong J.L., Keromes A., Rathat C., et al. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia. J Nucl Med 31 (1990) 34-37
20. Sakata K., Shirotani M., Yoshida H., and Kurata C. Cardiac sympathetic nervous system in early essential hypertension assessed by 123I-MIBG. J Nucl Med 40 (1999) 6-11
21. Kuwahara T., Hamada M., and Hiwada K. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 39 (1998) 1486-1491
22. Agostini D., Babatasi G., Manrique A., Saloux E., Grollier G., Potier J.C., et al. Impairment of cardiac neuronal function in acute myocarditis: iodine-123-MIBG scintigraphy study. J Nucl Med 39 (1998) 1841-1844
23. Matsuo S., Nakamura Y., Tsutamoto T., and Kinoshita M. Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy. J Nucl Cardiol 9 (2002) 407-412
24. Otsuka N., Ohi M., Chin K., Kita H., Naguchi T., Hata T., et al. Assessment of cardiac sympathetic function with iodine-123-MIBG imaging in obstructive sleep apnea syndrome. J Nucl Med 38 (1997) 567-572
25. Hattori N., Tamaki N., Hayashi T., Masuda I., Kudon T., Tateno M., et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 37 (1996) 1985-1990
26. Morozumi T., Kusuoka H., Fukuchi K., Tani A., Uehara T., Matsuda S., et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 38 (1997) 49-52